» Articles » PMID: 17126541

New and Emerging Roles for Mast Cells in Host Defence

Overview
Publisher Elsevier
Date 2006 Nov 28
PMID 17126541
Citations 111
Authors
Affiliations
Soon will be listed here.
Abstract

Mast cells are highly effective sentinel cells, found close to blood vessels and especially common sites of potential infection, such as the skin, airways and gastrointestinal tract. Mast cells participate actively in the innate immune responses to many pathogens through a broad spectrum of mediators that can be selectively generated. They also have a role as innate effector cells in enhancing the earliest processes in the development of acquired immune responses. Studies of bacterial and parasitic models have revealed mast cell dependent regulation of effector cell recruitment, mucosal barrier function and lymph node hypertrophy. An important role for mast cells in viral infection is also implied by several in vivo and in vitro studies. There are multiple direct and indirect pathways by which mast cells can be selectively activated by pathogens including Toll-like receptors, co-receptors and complement component receptors. Understanding the mechanisms and scope of the contribution of mast cells to host defence will be crucial to regulating their activity therapeutically.

Citing Articles

Anti-microbial cetylpyridinium chloride suppresses mast cell function by targeting tyrosine phosphorylation of Syk kinase.

Obeng B, Bennett L, West B, Wagner D, Fleming P, Tasker M J Immunotoxicol. 2025; 21(1):2443397.

PMID: 39815634 PMC: 11827644. DOI: 10.1080/1547691X.2024.2443397.


Antimicrobial cetylpyridinium chloride causes functional inhibition of mitochondria as potently as canonical mitotoxicants, nanostructural disruption of mitochondria, and mitochondrial Ca efflux in living rodent and primary human cells.

Weller S, Burnell J, Aho B, Obeng B, Ledue E, Shim J Food Chem Toxicol. 2024; 186:114547.

PMID: 38408634 PMC: 11060648. DOI: 10.1016/j.fct.2024.114547.


Exploiting innate immunity for cancer immunotherapy.

Yi M, Li T, Niu M, Mei Q, Zhao B, Chu Q Mol Cancer. 2023; 22(1):187.

PMID: 38008741 PMC: 10680233. DOI: 10.1186/s12943-023-01885-w.


Mast Cells as a Target-A Comprehensive Review of Recent Therapeutic Approaches.

Baran J, Sobiepanek A, Mazurkiewicz-Pisarek A, Rogalska M, Gryciuk A, Kuryk L Cells. 2023; 12(8).

PMID: 37190096 PMC: 10136699. DOI: 10.3390/cells12081187.


Regulation of Syk activity by antiviral adaptor MAVS in FcεRI signaling pathway.

Kawakami Y, Kimura M, Widjaja C, Kasakura K, Ando T, Kawakami Y Front Allergy. 2023; 4:1098474.

PMID: 37168500 PMC: 10165108. DOI: 10.3389/falgy.2023.1098474.